JetBlue Airways (NASDAQ:JBLU) has done nothing since July 2010, according to Soleil, and downgraded the company on low earnings and expectations.
Soleil says, "We are reducing our investment rating on JBLU, slashing our 2011 EPS estimate to $0.32 from $0.46, with consensus currently at $0.50 and, for 2012, are introducing a $0.57 forecast, up 79% from this year...JBLU shares have literally done nothing since our 23 July 2010 upgrade to Buy from Hold, but the Amex Airline Index has risen 20% and the S&P 500 is up 18% over that time frame. We take that weak relative performance as a sign of low expectations, but probably not as low as flat 2011 earnings, and are therefore most comfortable for now on the sidelines here."
Soleil Securities downgraded JetBlue Airways (JBLU) from Buy
to Hold. JetBlue closed Friday at $5.88, falling $0.52, or 8.12 percent. Soleil cut their price target on JetBlue from $8 to $7.
Monday, January 31, 2011
JetBlue Airways (NASDAQ:JBLU) Downgraded, EPS Lowered Far Below Consensus
Myriad Genetics (NASDAQ:MYGN) Downgraded on Lack of Catalysts
Myriad Genetics (NASDAQ:MYGN) was downgraded by Soleil Securities, with the company citing several concerns they have going forward.
Soleil analyst says, "Our Concerns for 2011/12: 1) A maturing BRACAnalysis franchise. 2) Nominal sales contribution from new products. 3) Potential headline risks associated with development challenges for PARP inhibitors and BRACAnalysis companion tests. 4) ACLU patent challenge case...Model Changes: We're looking for FY11 sales of $389.8MM and EPS of $1.01 - for FY12, we're keeping
expectations intact including sales of $415.2MM and EPS of $1.10."
Soleil Securities downgraded Myriad Genetics (MYGN) from Buy
to Hold. Myriad closed Friday at $19.30, dropping $3.11, or 13.88 percent. Soleil lowered their price target on Myriad from $22 to $20.
Thursday, January 27, 2011
Alaska Air (NYSE:ALK) Top Low-Risk Airline Stock Says Soleil
Alaska Air (NYSE:ALK) is considered the top low-risk airline stock by Soleil Securities, which raised its EPS estimates on the company, along with its price target.
Soleil says, "ALK has significant opportunities to enhance shareholder value with share repurchases and, ultimately but not imminently, a dividend. The free cash flow yield on 2011 estimates is an attractive 13% at the current stock price."
Soleil boosted their full year 2011 EPS estimate from $7.35 to $7.85 on Alaska Air, and introduced their full year 2012 EPS estimate at $9.00.
They maintain their "Buy" rating on Alaska Air, which closed Wednesday at $61.06, losing $0.07, or 0.11 percent. Soleil raised their price target on ALK from $70 to $74.
Friday, January 14, 2011
TransDigm (NYSE:TDG) EPS Growth Rate Boosted on McKechnie, Recovering Aerospace OEM
Soleil raised their EPS estimates on TransDigm (NYSE:TDG) for the next three to five years, citing the acquisition of McKechnie and the recovery of aerospace OEM.
Soleil says, "We are raising our estimates to $3.92 for FY11 (from $3.83 previously) and $4.64 for FY12 (from $4.36), and our three-to-five year EPS growth rate to 16% (from 14%) due to potential from the purchase of McKechnie and a recovering aerospace OEM and aftermarket...With an over 90% proprietary product mix and around 80% from sole source sales, we believe TransDigm benefits from a significant barrier to entry...High margin aftermarket sales (55% of the total and 85% of EBITDA), are now rebounding due to improving airline traffic."
Soleil Securities reiterates a "Buy" on TransDigm, which closed Thursday at $76.44, down $0.16, or 0.21 percent. Soleil raised their price target on TransDigm from $80 to $96.
Accumulate Lear (NYSE:LEA) on Weakness says Soleil
Citing awarded business, increased industry build assumptions and company comments, increased their PT on Lear (NYSE:LEA), but recommend buying the company on weakness as the supplier segment looks volatile.
Soleil noted, "We have increased our earnings assumptions for Lear for 2010, 2011 and 2012 to reflect higher industry build assumptions in North America and in Europe, an increase in awarded business, and recent company comments...We have increased our target price as the market increasingly looks to 2012 earnings, but believe the supplier group will remain volatile, presenting better buying opportunities over the coming months and look to accumulate the stock on weakness."
Soleil Securities reiterates a "Hold" on Lear, which closed Thursday at $106.74, gaining $0.56, or 0.53 percent. Soleil raised their price target on Lear from $96 to $109.
Wednesday, January 12, 2011
Stryker (NYSE:SYK) EPS Growth Rate Estimate Boosted by Soleil
Stryker Corp. (NYSE:SYK) had its EPS estimates raised by Soleil, with overall growth rates for the next three to five years projected to reach an average of 15 percent; an increase over the previous estimate of 13 percent.
Consequently Soleil is raising their full year EPS estimates for 2010 and 2011 to $3.30 and $3.77 to $3.33 and $3.92.
In the fourth quarter Stryker repurchased 6.1 million share at $51.50 a share, or $314 million.
Soleil Securities maintains their "Buy" rating on Stryker, which closed Tuesday at $58.00, gaining $3.30, or 6.03 percent. Soleil boosted their price target on them from $71 to $84.
Tuesday, January 11, 2011
United Continental (NYSE:UAL) Risky on Merger Integration, But Has Strong Potential
United Continental (NYSE:UAL) has some significant risk from the integration of their merger, but also, according to Soleil, has the highest potential in the sector.
Soleil said, "UAL has for us above-average risk owing to its ongoing merger integration, but also has the highest stock price return potential in the group."
They increased their full year 2011 estimate from $4.90 to $5, citing higher fuel costs and poor weather. They also boosted their 4Q10 EPS estimate by $0.06 to $0.30 and their full year 2010 from $4.10 to $4.15.
Soleil maintains a "Buy" rating on United Continental, which closed Monday at $26.20, gaining $0.25, or 0.96 percent. They raised their price target on United from $33 to $35.
Analysts Getting Frisky with Ford (NYSE:F)
So many analysts are turning bullish on Ford (NYSE:F) it causes one to pause and take a breather to see if it's getting too positive out there.
UBS (NYSE:UBS) added shares of Ford to their "Key Calls List," while also increasing their price target from $19 to $21.
Barclays (NYSE:BCS) raised their price target to a new Street high of $23, raising it from it prior target of $17. Barclays has an "Overweight" rating on Ford.
Soleil has a "Buy" rating on Ford and bumped up their price target from $20 to $22.
Even Credit Suisse (NYSE:CS), which has an "Underperform" on Ford increased their price target on them from $14 to $17.
It wouldn't be surprising for Ford to pull back some after their run-up over the last couple of months, as they've went up fast for a company that hasn't proved yet it can execute.
Ford closed Monday at $18.31, up $0.04, or 0.22 percent.
Thursday, January 6, 2011
Mosaic's (NYSE:MOS) EPS Estimates Raised on Strong Performance
The solid beat by Mosaic (NYSE:MOS) in the second quarter for earnings per share caused Soleil Securities to raise their full year estimate on the fertilizer company for 2011.
Soleil said, "2QF11 EPS of $1.01 beat Street consensus for $0.91 due to higher-than-expected phosphate shipments, prices, and therefore gross margin, partially offset by higher-than-expected potash royalties...We raise our F2011E on the 2QF11 beat and better-than-expected guidance for 3QF11 on continued momentum in phosphates. We tweak our well-above-consensus F2012E on higher potash royalties."
Soleil Securities maintains a "Hold" rating on Mosaic, which was trading at $0.95, gaining $1.23 percent, as of 11:35 AM EST. Soleil boosted their price target on Mosaic from $70 to $84.
Wednesday, December 29, 2010
ICU Medical (NASDAQ:ICUI) Faces Weak Flu Season, Gross Margin Pressures
ICU Medical (NASDAQ:ICUI) had its EPS estimates lowered by Soleil Securities, citing a weak flu season and pressures on gross margins.
Soleil said, "Bottom-Line: We're adjusting 4Q:10 estimates for ICU-Medical (ICUI-Buy) on: 1) Short-term gross margin pressure from a new manufacturing facility. 2) A weak flu season, which might negatively impact product sales...We've lowered our 4Q:10E sales to $71.5MM (previous $72.5MM) on lower consumable sales. We've lowered our 4Q:10E EPS to $0.55 (previous $0.58)--$0.01 from lower sales and $0.02 on lower gross margins. Introducing CY12 sales/EPS of $328.2MM/$2.45."
Soleil Securities maintains a "Buy" rating on ICU Medical, which closed Tuesday at $36.75, down $0.15, or 0.41 percent. Soleil lowered their price target on the company from $43 to $42.
Monday, December 27, 2010
Compass Minerals (NYSE:CMP) Getting Strong Seasonal Start with Cold December
With ice control being a major part of Compass Minerals (NYSE:CMP) business in the colder months, the cold winter this year should help them in the North American and British markets.
Soleil said, "Old-man-winter. Anecdotal evidence suggests that the '10-'11 winter is off to a strong start for the month of December 2010, in both North America and the U.K. This should boost Compass' ice control earnings, one third of company total...We increase our price target to $100 (from $88), on rolling out our 2012E EPS estimate of $6.91, which is now our out-year forecast...SOP follows MOP. Compass is a price follower in specialty potash, 25% of its earnings, and we assume it attempts to maintain a price premium over MOP of $150-200/short ton. It has announced three SOP price increases during 4Q10E that total to $80/short ton (15%), and should be realized through 1QF11E."
Soleil Securities maintains a "Buy" rating on Compass Minerals International, which was trading at $87.96, down $0.74, or 0.83 percent, as of 12:07 PM EST. Soleil raised their price target on them from $88 to $100.
Friday, December 17, 2010
Southwest Airlines (NYSE:LUV) Boosted on Revenue Momentum
Southwest Airlines (NYSE:LUV) had its rating upgraded by Soleil Securities, citing strong revenue momentum and their patient handling of the AirTran acquisition.
Soleil said, "First, revenue momentum remains strong and suggest upside to our 2011 forecast, which reflects much higher fuel prices than before - prices suggested by management that are higher than our reading of the forward curve. A second driver of the upgrade is a stronger sense that Southwest is going to handle the AirTran acquisition with a very light touch, taking their time in integrating it and reducing merger integration risk in the process while driving revenue benefits early on via increased connecting opportunities."
Southwest Airlines was upgraded to a "Buy" rating, and was trading at $12.85, up $0.21, or 1.66 percent, as of 11:55 AM EST. Soleil has a price target of $15 on them.
Monday, December 6, 2010
DuPont (NYSE:DD) to be Driven be Emerging Market Sales
Citing emerging markets generating about 35 to 40 percent of mature business sales in 2011, Soleil Securities maintained their "Buy" rating on DuPont (NYSE:DD) while raising their price target.
Citigroup recently raised their rating on DuPont to "Buy."
EPS estimates were placed by Soleil for 2012 of $4.25.
DuPont was trading at $48.82, down by $0.41, or 0.83 percent. The price target on DuPont was boosted from $55 to $60.
Wednesday, December 1, 2010
Thor Industries (NYSE:THO) RV Sales Increase Not Enough
While revenue for the latest quarter increased by 21 percent for Thor Industries (NYSE:THO), the cost of that growth was highlighted by the disappointing earnings they posted, which underscored the shrinking margins coming from lowered prices.
Prices had to be slashed so much that Thor misses earnings estimates by $0.10 a share, coming in at $0.44, down from analysts' expectations of $0.54.
When revenue increases that much at that high of a cost, the discounting had to be enormous to generate revenue.
The major question going forward is if Thor has any real control of their pricing, or if the macro-economic picture is the driver behind it.
What is very positive for the company is its no-debt and strong cash position. That gives them more flexibility than some of their competitors may have, allowing them to wait out the ongoing recession and still generate revenue, albeit at higher costs.
Soleil Securities lowered their EPS estimate on the company for full year 2011 from $2.56 to $2.45, and for full year 2012 from $3.00 to $2.90.
Thor plummeted Tuesday, closing at $29.53, falling $4.11, or 12.22 percent. Soleil has a price target on them of $50, dropping it from $51. They maintain a "Buy" rating on them.
Monday, November 22, 2010
Health Management (NYSE:HMA) Outperforming Industry in Revenue Growth
Health Management (NYSE:HMA) is in the middle of a major turnaround, leading the sector in revenue growth. Soleil Securities has maintained their "Buy" rating on them while raising their price target.
Soleil reported, "HMA is in the heart of its turnaround phase, outperforming the industry on revenue growth (solid surgical growth) and same-hospital margin expansion (incremental cost control), and is aggressively building its revenue base via attractively priced acquisitions. We continue to recommend purchase of HMA shares."
Earnings estimates for full year 2011 were raised from $0.67 to $0.72, and EBITDA from $782 million to $800 million.
Health Management closed up Friday at $8.67, gaining $0.05, or 0.58 percent. Soleil has a price target of $10 on them, raising it from $9.
AMR (NYSE:AMR) Least Favorite Among Airline Stocks for Soleil
Soleil Securities has maintained their "Hold" rating on AMR Corp. (NYSE:AMR), while raising their price target and EPS on them.
"While we are slightly raising our 2010 and 2011 EPS forecast to a rounded loss of ($1.30) from ($1.50) and a profit of $0.20 from $0.10, respectively, those changes are driven by stronger expected revenues and some offset from higher fuel prices," Soleil said.
Even so, they added, "we view AMR shares as being on a short leash, overvalued if they continue their rise without an accompanying improvement in the fundamental and, especially, the labor outlook. Our rating on AMR remains Hold, but it is our least favorite airline stock."
AMR closed Friday slightly up at $8.24, rising $0.01, or 0.12 percent. Soleil has a price target of $8 on the airline, increasing it from $6.
Thursday, November 18, 2010
LDK Solar (NYSE:LDK) Will Struggle as Debt Levels are High
LDK Solar (NYSE:LDK) was downgraded by Soleil Securities today, citing the overall underestimation of the large debt the company carries. They downgraded them from "Buy" to "Sell."
Soleil said, "As we noted in a Sunburst last week (November 12th), we believe the odds are high (65%) that the PV industry has passed an inflection point, and fears of extreme overcapacity in 2011, particularly in the second half of the year, are now going to dominate the investment outlook for the PV stocks... We believe investors are under-estimating the true level of LDK's net debt. In talking to investors we find most have overlooked the sharp growth in the company's Accrued Expenses over the last two-and-a-half years (from roughly $100mm to roughly $700mm)."
LDK was trading up today, coming in at $11.08, gaining $0.11, or 1.00 percent as of 1:02 PM EST.
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)